Merakris Therapeutics
PrivateMomentum
Top 50%
of companies Caplight tracks
Company Overview
Merakris Therapeutics is a biotechnology company that researches, develops, and commercializes regenerative healthcare products for wound care.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Drug Discovery, Clinical Trials
Business Model
B2G
Customer Profile
Government Contracts, Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Merakris Therapeutics Comparables
Compare Merakris Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Skye Biologics Holdings | 84% | |
| BIOHEAL Therapeutics | 80% | |
| BioStem Technologies Inc | 77% |
Merakris Therapeutics Funding Rounds
Historical fundraising activity
Key People
Founding team and executive leadership
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 16, 2026
Monthly visitors grew 71% MoM, reaching 4.9K.
- Sep 4, 2025
Attending SAWC Fall 2025 to highlight clinical programs.
Recent news
Latest coverage and updates
- launchesSep 8, 2026
Merakris Therapeutics, Inc. launched AmnioSurge on Sep 8th '26.
- partners_withSep 8, 2026
Merakris Therapeutics, Inc. partnered with 360 Medical on Sep 8th '26.
- receives_financingJul 21, 2026
Merakris Therapeutics, LLC received financing of $2.2M in Direct-to-Phase II Small Business Innovation Research on Jul 21st '26.
- signs_new_clientJun 17, 2026
Merakris Therapeutics, LLC signed new client Veterans Affairs on Jun 15th '26.
Merakris Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Merakris Therapeutics's valuation, stock price, and market status.
Is Merakris Therapeutics a public or private company?
Merakris Therapeutics is a private company.
What is the current stock price of Merakris Therapeutics?
Merakris Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Merakris Therapeutics worth (valuation)?
Valuation information for Merakris Therapeutics is not publicly available.
Can I buy Merakris Therapeutics stock?
Merakris Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Merakris Therapeutics's last funding round?
Funding round information for Merakris Therapeutics is not publicly available.
Who are the main investors in Merakris Therapeutics?
Investor information for Merakris Therapeutics is not publicly disclosed.
Will Merakris Therapeutics IPO soon?
No public IPO plans have been announced for Merakris Therapeutics.
How can I track Merakris Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Merakris Therapeutics's secondary market activity and sign up for updates.